Vaccine

Details Vaccine Vaccine

A - Human Necessities

61

K

A61K 39/12 (2006.01)

Patent

CA 2606092

A method for prevention of HPV infection and/or disease, the method comprising delivery of a first HPV vaccine comprising an L1 protein or immunogenic fragment thereof from at least HPV 16 and HPV 18, and a second HPV vaccine which does not comprise the HPV 16 and HPV 18 L1 components from the first vaccine, and which second vaccine comprises an L1 protein or immunogenic fragment thereof from at least one other oncogenic HPV type, wherein the first and second vaccines may be delivered in either order and delivery is separated by a suitable time interval.

L'invention concerne une méthode destinée à prévenir une infection à VPH et/ou une maladie liée au VPH, et consistant à administrer un premier vaccin anti-VPH renfermant un fragment immunogène ou de protéine L1 correspondant obtenu au moins à partir de VPH 16 et VPH 18, et un second vaccin anti-VPH ne comprenant pas les constituants L1 de VPH 16 et VPH 18 obtenu à partir du premier vaccin, ce second vaccin renfermant un fragment immunogène ou de protéine L1 correspondant obtenu à partir d'au moins un autre type de VPH oncogène, lesdits premier et second vaccins pouvant être administrés dans n'importe quel ordre, les administrations étant séparées par un intervalle de temps approprié.

Affiliated with

Also associated with

Rating

Vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1849886